🔎 Trials Near Me

Home › Ovarian Epithelial Carcinoma › North Carolina

Ovarian Epithelial Carcinoma clinical trials in North Carolina

9 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in North Carolina.

Cities in North Carolina

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • University of North Carolina Medical Center /ID# 275307, Chapel Hill
  • Atrium Health Levine Cancer Institute /ID# 274557, Charlotte
  • East Carolina University - Brody School of Medicine /ID# 275770, Greenville
  • and 1 more
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • UNC- Chapel Hill, Chapel Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  • Research Site, Chapel Hill
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • UNC Hospital, Chapel Hill
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

  • Lineberger Comprehensive Cancer Center, Chapel Hill
RecruitingPhase 1
Ages 18 and older · Women · Updated May 19, 2026 · NCT06305299

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

  • Site 0259, Durham
RecruitingPhase 1
Ages 18 and older · Women · Updated Apr 7, 2026 · NCT04516447

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  • Duke Cancer Center, Durham
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775

A Study of NX-1607 in Adults With Advanced Malignancies

  • University of North Carolina, Chapel Hill
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Levine Cancer Institute, Charlotte
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.